Regional Cooperation, Intellectual Property Law and Access to Medicines
A Holistic Approach for Least Developed Countries
Series: Routledge Research in Health Law;
- Publisher's listprice GBP 42.99
-
20 538 Ft (19 560 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 4 108 Ft off)
- Discounted price 16 430 Ft (15 648 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
20 538 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher Routledge
- Date of Publication 27 May 2025
- ISBN 9781032379043
- Binding Paperback
- No. of pages156 pages
- Size 234x156 mm
- Weight 290 g
- Language English 665
Categories
Short description:
This book examines the potential for regionalization of intellectual property law and policy as a means of improving pharmaceutical access for least developed countries. It takes the East African Community as a case study of developing and least developed countries to illustrate why and how a regional collective approach is preferred.
MoreLong description:
This book examines the potential for regionalisation of intellectual property law and policy as a means of improving pharmaceutical access for least developed countries. The challenge of sustainable access to pharmaceuticals continues to be an issue of global significance. While much has been written on emerging economies in this context, least developed countries have been largely overlooked. This book fills this gap by taking the East African Community as a case study of developing and least developed countries to illustrate why and how a regional collective approach is preferred. It adopts a holistic approach in finding sustainable solutions to both IP and non-IP barriers to pharmaceutical access across a range of inter-related issues through a regional cooperative scheme. It evaluates factors that are necessary for successful regional cooperation, such as legal and policy coherence, WTO rule compliance, the threat of protectionism, regional competition rules, and so on, in order to produce legal and policy recommendations relevant to both existing and intending regional coalitions desiring to improve pharmaceutical access. It also looks beyond the scope of IP barriers to pharmaceutical access, examining non-IP-related factors such as pharmaceutical market intelligence, local pharmaceutical manufacturing capacity, economies of scale and purchasing power, medical regulation and quality assurance, technology transfer, and market size amongst others. The book will be an invaluable resource for academics, researchers and policy-makers working in the areas of Public Health Law, International Trade Law, Intellectual Property Law and Development Studies.
MoreTable of Contents:
1. Setting the Scene: The Context and the Problem; 2. Contextual Analysis of East African Countries' Healthcare Systems and Epidemiology; 3. Leveraging TRIPS Flexibilities for Pharmaceutical Access- A Survey of EAC Partner States’ Patent Laws; 4. TRIPS Amendment’s Special Regional Treatment- An Appraisal; 5. The Feasibility or Otherwise of Regional Pharmaceutical Production in the EAC; 6. Regional Cooperation, Human Rights and Equitable Vaccine Distribution - The COVID-19 Pandemic Experience; 7. Charting the regional cooperative path
International Encyclopaedia of Comparative Law
333 060 HUF
293 093 HUF
